Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sleep Initiation and Maintenance Disorders | 19 | 2025 | 99 | 4.470 |
Why?
|
| Sleep Wake Disorders | 10 | 2025 | 203 | 3.030 |
Why?
|
| Sleep | 16 | 2024 | 366 | 1.950 |
Why?
|
| Menopause | 7 | 2025 | 86 | 1.500 |
Why?
|
| Pregnancy Complications | 4 | 2022 | 540 | 1.010 |
Why?
|
| Women's Health | 4 | 2019 | 133 | 0.810 |
Why?
|
| Actigraphy | 4 | 2025 | 52 | 0.730 |
Why?
|
| Restless Legs Syndrome | 1 | 2022 | 16 | 0.730 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2023 | 238 | 0.710 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2022 | 80 | 0.680 |
Why?
|
| Hospitalization | 2 | 2025 | 1932 | 0.620 |
Why?
|
| Mood Disorders | 1 | 2019 | 127 | 0.560 |
Why?
|
| Pain | 1 | 2020 | 429 | 0.540 |
Why?
|
| Premature Birth | 1 | 2022 | 422 | 0.530 |
Why?
|
| Postpartum Period | 1 | 2019 | 238 | 0.510 |
Why?
|
| Menstrual Cycle | 3 | 2024 | 32 | 0.500 |
Why?
|
| von Willebrand Factor | 1 | 2018 | 191 | 0.490 |
Why?
|
| Interleukin-6 | 1 | 2018 | 410 | 0.480 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 892 | 0.420 |
Why?
|
| Melatonin | 4 | 2013 | 30 | 0.330 |
Why?
|
| Inflammation | 1 | 2018 | 1482 | 0.320 |
Why?
|
| Female | 28 | 2025 | 70422 | 0.300 |
Why?
|
| Circadian Rhythm | 5 | 2019 | 315 | 0.290 |
Why?
|
| Affect | 3 | 2025 | 161 | 0.280 |
Why?
|
| Sleep Medicine Specialty | 2 | 2020 | 12 | 0.280 |
Why?
|
| Emotions | 2 | 2024 | 349 | 0.260 |
Why?
|
| Polysomnography | 5 | 2024 | 154 | 0.260 |
Why?
|
| Depression | 5 | 2025 | 1316 | 0.250 |
Why?
|
| Humans | 35 | 2025 | 130525 | 0.240 |
Why?
|
| Postmenopause | 2 | 2017 | 136 | 0.230 |
Why?
|
| Delirium | 1 | 2025 | 65 | 0.220 |
Why?
|
| Adult | 16 | 2025 | 31173 | 0.210 |
Why?
|
| Surveys and Questionnaires | 5 | 2025 | 4025 | 0.210 |
Why?
|
| Sleep Apnea, Central | 1 | 2023 | 10 | 0.190 |
Why?
|
| Natural Language Processing | 1 | 2024 | 76 | 0.190 |
Why?
|
| Depressive Disorder | 3 | 2012 | 460 | 0.190 |
Why?
|
| Stress, Psychological | 2 | 2025 | 539 | 0.190 |
Why?
|
| Stroke Rehabilitation | 1 | 2023 | 65 | 0.180 |
Why?
|
| Middle Aged | 16 | 2024 | 28450 | 0.180 |
Why?
|
| Menstruation | 1 | 2021 | 24 | 0.170 |
Why?
|
| Self-Management | 1 | 2023 | 120 | 0.170 |
Why?
|
| Body Mass Index | 4 | 2018 | 1678 | 0.170 |
Why?
|
| Aged | 9 | 2025 | 20930 | 0.160 |
Why?
|
| Cognition | 3 | 2021 | 811 | 0.160 |
Why?
|
| Social Media | 1 | 2022 | 119 | 0.160 |
Why?
|
| Machine Learning | 1 | 2024 | 383 | 0.160 |
Why?
|
| Dreams | 1 | 2020 | 23 | 0.160 |
Why?
|
| Pregnancy | 4 | 2022 | 7411 | 0.160 |
Why?
|
| Progesterone | 3 | 2012 | 440 | 0.150 |
Why?
|
| Advisory Committees | 1 | 2020 | 148 | 0.150 |
Why?
|
| Pregnancy Outcome | 1 | 2022 | 615 | 0.140 |
Why?
|
| Ovariectomy | 1 | 2019 | 154 | 0.140 |
Why?
|
| Cesarean Section | 1 | 2022 | 426 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 6813 | 0.140 |
Why?
|
| Behavior Therapy | 1 | 2021 | 271 | 0.140 |
Why?
|
| Berlin | 1 | 2018 | 3 | 0.140 |
Why?
|
| Hot Flashes | 1 | 2018 | 6 | 0.140 |
Why?
|
| Orgasm | 1 | 2017 | 6 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2024 | 645 | 0.130 |
Why?
|
| Texas | 1 | 2025 | 3642 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2025 | 877 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2024 | 818 | 0.120 |
Why?
|
| Pandemics | 2 | 2022 | 1159 | 0.120 |
Why?
|
| Dementia | 1 | 2021 | 433 | 0.120 |
Why?
|
| Behavioral Medicine | 1 | 2016 | 11 | 0.120 |
Why?
|
| Geographic Mapping | 1 | 2016 | 15 | 0.120 |
Why?
|
| Pilot Projects | 1 | 2020 | 1449 | 0.120 |
Why?
|
| Societies, Medical | 1 | 2020 | 796 | 0.120 |
Why?
|
| Male | 13 | 2025 | 64514 | 0.120 |
Why?
|
| Medically Underserved Area | 1 | 2016 | 87 | 0.110 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 446 | 0.110 |
Why?
|
| Sexual Behavior | 1 | 2017 | 231 | 0.110 |
Why?
|
| Intimate Partner Violence | 1 | 2015 | 30 | 0.110 |
Why?
|
| Stroke | 1 | 2023 | 1056 | 0.110 |
Why?
|
| Young Adult | 7 | 2025 | 10007 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2018 | 612 | 0.110 |
Why?
|
| Affective Symptoms | 1 | 2015 | 62 | 0.110 |
Why?
|
| Phenotype | 1 | 2024 | 4479 | 0.110 |
Why?
|
| Insulin Resistance | 1 | 2018 | 687 | 0.100 |
Why?
|
| Hydrocortisone | 1 | 2013 | 212 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2018 | 1343 | 0.090 |
Why?
|
| Estradiol | 2 | 2012 | 463 | 0.090 |
Why?
|
| Mental Health | 1 | 2015 | 371 | 0.090 |
Why?
|
| Seasons | 1 | 2013 | 333 | 0.090 |
Why?
|
| Veterans | 1 | 2023 | 1790 | 0.080 |
Why?
|
| Neoplasms | 2 | 2024 | 2956 | 0.080 |
Why?
|
| Heart Failure | 1 | 2023 | 2337 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2022 | 8528 | 0.070 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2009 | 47 | 0.070 |
Why?
|
| Biomarkers | 1 | 2018 | 3387 | 0.070 |
Why?
|
| Comorbidity | 2 | 2024 | 1585 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2007 | 177 | 0.060 |
Why?
|
| Estrogens | 1 | 2009 | 427 | 0.060 |
Why?
|
| Adolescent | 5 | 2025 | 20739 | 0.060 |
Why?
|
| Sexual Partners | 2 | 2017 | 80 | 0.060 |
Why?
|
| Retrospective Studies | 4 | 2025 | 17567 | 0.050 |
Why?
|
| Unsupervised Machine Learning | 1 | 2024 | 12 | 0.050 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 956 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2012 | 833 | 0.050 |
Why?
|
| Benzhydryl Compounds | 1 | 2004 | 78 | 0.050 |
Why?
|
| Logistic Models | 2 | 2019 | 1812 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2007 | 554 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2024 | 412 | 0.050 |
Why?
|
| Hemiplegia | 1 | 2023 | 40 | 0.050 |
Why?
|
| Quality of Life | 2 | 2024 | 2080 | 0.050 |
Why?
|
| Neuroprotective Agents | 1 | 2004 | 162 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2025 | 899 | 0.050 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 169 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2025 | 1065 | 0.040 |
Why?
|
| Fatigue | 1 | 2021 | 193 | 0.040 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 3038 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1486 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 5079 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 350 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1397 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2012 | 938 | 0.040 |
Why?
|
| Medicare | 1 | 2023 | 439 | 0.040 |
Why?
|
| Goals | 1 | 2020 | 126 | 0.040 |
Why?
|
| Survivors | 1 | 2021 | 344 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2021 | 12861 | 0.030 |
Why?
|
| Age Factors | 1 | 2024 | 2837 | 0.030 |
Why?
|
| Risk Factors | 2 | 2025 | 10975 | 0.030 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2017 | 75 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 3806 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 187 | 0.030 |
Why?
|
| Cities | 1 | 2016 | 51 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2017 | 92 | 0.030 |
Why?
|
| Acute Disease | 1 | 2018 | 1149 | 0.030 |
Why?
|
| Health Personnel | 1 | 2020 | 549 | 0.030 |
Why?
|
| United States | 2 | 2023 | 11894 | 0.030 |
Why?
|
| Darkness | 1 | 2013 | 26 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 1541 | 0.030 |
Why?
|
| Periodicity | 1 | 2013 | 47 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1293 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 305 | 0.020 |
Why?
|
| Light | 1 | 2013 | 171 | 0.020 |
Why?
|
| Time Factors | 2 | 2013 | 6205 | 0.020 |
Why?
|
| California | 1 | 2012 | 126 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2011 | 240 | 0.020 |
Why?
|
| Child | 2 | 2021 | 26104 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 686 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2011 | 461 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 249 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2011 | 459 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6447 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 2007 | 119 | 0.020 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 78 | 0.020 |
Why?
|
| Reaction Time | 1 | 2007 | 156 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 170 | 0.020 |
Why?
|
| Perception | 1 | 2007 | 229 | 0.010 |
Why?
|
| Memory | 1 | 2007 | 354 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5183 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 3680 | 0.010 |
Why?
|